Financial Enhancement Group LLC Gsk PLC Transaction History
Financial Enhancement Group LLC
- $545 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding GSK
# of Institutions
21Shares Held
175KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.68 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.3 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$776,2950.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL16.5KShares$639,5780.0% of portfolio
-
Loveless Wealth Management LLC15KShares$582,9880.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $79B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...